Endotype DIrected Treatment for OSA in Down Syndrome
Endotype DIrected Treatment for OSA in Down Syndrome
Recruiting · NCT07280468 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Endotype DIrected Treatment for OSA in Down Syndrome | Abnormalities, Multiple, Apnea, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Dyssomnias, Neurobehavioral Manifestations, Neurologic Manifestations, Respiration Disorders, Sleep Disorders, Intrinsic, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Phase 4 | 2026-09-03 | NCT07280468 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Patient-Centered Outcomes Research Institute | 213 |
| University of Arizona | 138 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advocate Medical Group Adult Down Syndrome Center | Park Ridge | United States | 2 |
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| University of Arizona | Tucson | United States | 53 |
| University of California San Diego | San Diego | United States | 1 |
| University of Miami | Miami | United States | 327 |